Page last updated: 2024-11-07

ino 2628-cz

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N'-dicyclopropylmethylpiperazine: structure given in first source; Ino 2628-CZ is the dichlorohydrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134119
SCHEMBL ID7331633
MeSH IDM0164712

Synonyms (13)

Synonym
piperazine, 1,4-bis(cyclopropylmethyl)-, dihydrochloride
n,n'-dicyclopropyl-methyl-piperazine-dichlorhydrate
ino-2628-cz
ino 2628-cz
ino-2628
ino-2628cz
n,n'-dicyclopropylmethylpiperazine
82909-97-5
n,n'-di(cyclopropylmethyl)piperazine dihydrochloride
SCHEMBL7331633
DTXSID401002998
1,4-bis(cyclopropylmethyl)piperazine--hydrogen chloride (1/2)
1,4-bis(cyclopropylmethyl)piperazine;dihydrochloride

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"A pharmacokinetic model with multiple, unequal, enterohepatic recirculations was developed to fit the experimental data of a new inotropic drug after intravenous infusion and oral administration."( Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.
Barre, J; de Biasi, J; Houin, G; Plusquellec, Y; Tillement, JP; Trenque, T, 1992
)
0.28

Dosage Studied

ExcerptRelevanceReference
"A distribution study was carried out on Cynomolgus monkeys (Macaca fascicularis) dosed orally with 14C-labelled N-N'-dicyclopropyl-methyl-piperazine-dichlor-hydrate 14C-Ino 2628-CZ and sacrificed 2, 8 and 24 h after dosage, using whole-body autoradiography."( Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 3rd communication: whole-body autoradiographic study in Cynomolgus monkeys after oral administration.
Alvinerie, M; Benard, P; Declume, C; Dormard, Y; Galtier, P; Houin, G; Malbosc, R; Tufenkji, AE, 1993
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.98 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]